Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone
Clinical trial NCT00907452 · COMPLETED
Trial details
- NCT number
- NCT00907452
- Sponsor
- Intergroupe Francophone du Myelome
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-29
- Primary completion
- 2010-12-14
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.